Optometry News

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Jay S. Pepose, MD, PhD, of Ocuphire Pharma, discusses an oral small-molecule Ref-1 inhibitor for nonproliferative diabetic retinopathy.

NASHVILLE, Tenn. — In this Healio video, William Reindel, OD, shares research that demonstrates a high level of patient satisfaction with Bausch + Lomb’s Infuse contact lenses, providing a practice growth opportunity for eye care providers.

New survey results from the AMA illustrate the burden of prior authorization, with many physicians reporting that it leads to serious patient harms, delays care, reduces work productivity and more.

NASHVILLE, Tenn. — Patients with keratoconus may need a variety of contact lenses after surgery, making it critical for clinicians to have multiple options in their toolbox, according to a speaker at Optometry’s Meeting.

The FDA granted breakthrough therapy and regenerative medicine advanced therapy designations for AURN001 for the treatment of corneal edema secondary to corneal endothelial disease, according to a press release from Aurion Biotech.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, David S. Boyer, MD, of Retina-Vitreous Associates Medical Group in Los Angeles, discusses targeting mitochondria in retinal disease treatment.

In addition to accidental ocular injury associated with e-cigarettes, chronic users may experience reduced tear film quality and stability, potentially increasing the risk for dry eye disease, according to a systematic review.

“We have enough votes to pull the plug.”

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Raj Agrawal, MD, discusses the initial results of a phase 2a study of a novel therapy for patients with diabetic macular edema.

Obstructive sleep apnea appears to increase the risk for ptosis repair failure and revision surgery, according to a study in Ophthalmic Plastic and Reconstructive Surgery.